CAMPOMENOSI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 8.288
EU - Europa 4.346
AS - Asia 2.908
SA - Sud America 369
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 58
OC - Oceania 17
Totale 16.093
Nazione #
US - Stati Uniti d'America 8.018
IT - Italia 2.099
SG - Singapore 850
CN - Cina 668
UA - Ucraina 528
VN - Vietnam 393
DE - Germania 355
TR - Turchia 336
SE - Svezia 320
HK - Hong Kong 313
BR - Brasile 299
RU - Federazione Russa 189
FI - Finlandia 187
GB - Regno Unito 184
CA - Canada 172
IE - Irlanda 145
FR - Francia 138
IN - India 77
BD - Bangladesh 57
MX - Messico 51
JP - Giappone 45
NL - Olanda 45
ES - Italia 42
PL - Polonia 26
AR - Argentina 22
BE - Belgio 22
IQ - Iraq 22
PK - Pakistan 19
ZA - Sudafrica 19
KR - Corea 17
AU - Australia 15
CO - Colombia 14
IR - Iran 13
CZ - Repubblica Ceca 12
EC - Ecuador 11
MY - Malesia 11
TW - Taiwan 11
EU - Europa 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
AT - Austria 8
CL - Cile 8
CR - Costa Rica 8
TH - Thailandia 8
ID - Indonesia 7
PH - Filippine 7
VE - Venezuela 7
GT - Guatemala 6
JM - Giamaica 6
LB - Libano 6
MA - Marocco 6
RO - Romania 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
DZ - Algeria 5
PR - Porto Rico 5
UZ - Uzbekistan 5
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
TN - Tunisia 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
HN - Honduras 3
IL - Israele 3
NO - Norvegia 3
SA - Arabia Saudita 3
BO - Bolivia 2
GP - Guadalupe 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
Totale 15.988
Città #
Milan 1.199
Ashburn 824
San Jose 705
Fairfield 613
Singapore 468
Chandler 460
Jacksonville 429
Woodbridge 395
Houston 319
Dallas 305
Hong Kong 305
Council Bluffs 266
Seattle 262
Ann Arbor 258
Wilmington 248
Beijing 199
Cambridge 193
Como 179
Princeton 153
Nyköping 149
The Dalles 148
Dublin 143
Izmir 138
New York 136
Dearborn 131
Los Angeles 126
Boardman 125
Dong Ket 111
Toronto 107
Chicago 93
Rome 84
Santa Clara 79
Lauterbourg 77
Kocaeli 61
Munich 56
San Diego 51
Ho Chi Minh City 47
Ponte Lambro 47
London 43
Orem 42
Hanoi 41
Moscow 41
San Mateo 40
Tokyo 36
Ogden 35
São Paulo 35
Helsinki 34
Varese 34
Guangzhou 33
Denver 32
Des Moines 30
Buffalo 29
Mexico City 27
Düsseldorf 26
Montreal 25
Naples 25
Chennai 24
Frankfurt am Main 24
Phoenix 24
Warsaw 24
Amsterdam 23
Langenfeld 22
Falls Church 21
Nanjing 21
Turku 21
Manchester 20
Atlanta 19
Brooklyn 19
Brussels 19
Gallarate 19
Washington 19
Shanghai 18
Hangzhou 16
Nuremberg 16
Stockholm 16
Johannesburg 15
Hefei 14
Mumbai 13
Salt Lake City 13
San Francisco 13
Da Nang 12
Poplar 12
Charlotte 11
Verona 11
Boston 10
Redwood City 10
Haiphong 9
Nairobi 9
Querétaro 9
Vancouver 9
Baghdad 8
Busto Arsizio 8
Jinan 8
Norwalk 8
Redmond 8
Turin 8
Auburn Hills 7
Bangkok 7
Berlin 7
Genoa 7
Totale 10.928
Nome #
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer 341
Proline Dehydrogenase affects Lung Adenocarcinoma cell survival, proliferation, and 3D growth 329
Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins 296
Proteomic analysis of MG132-treated germinating pollen reveals expression signatures associated with proteasome inhibition 284
Proline Dehydrogenase affects lung cancer cell proliferation by inducing ROS and cellular senescence 272
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. 267
TAS2R38 taste receptor gene and chronic rhinosinusitis: a bitter ending 244
Effect of inulin on proteome changes induced by pathogenic lipopolysaccharide in human colon 241
Abstract 3402: ΔN-p63α and TA-p63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites 239
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment 238
Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2 236
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 235
TAS2R38 taste receptor gene and chronic rhinosinusitis: new data from an Italian population 232
Biochemical and immunohistochemical characterization of human RNASET2 expression 227
5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation. 225
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma 224
Defective splicing induced by 4NQO in the hamster hprt gene. 224
Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair. 222
Expression of proline dehydrogenase in non-small cell lung cancer: immunohistochemical characterization and possible regulators. 220
TRP channels expression in Chronic Low Back Pain 219
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. 217
Derivative chromosome 17 in a case of Burkitt lymphoma with 8;14 translocation. 216
Emerging role of Proline dehydrogenase in 2D and 3D growth of lung cancer cells resistant to tyrosine kinase inhibitors 215
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line 215
Defective nuclear localization of p53 protein in a Chinese hamster cell line is associated with the formation of stable cytoplasmic protein multimers in cells with gene amplification. 214
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene 212
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay 209
A dual role of Proline Dehydrogenase in Lung Cancer 206
ΔN-p63a and ta-p63a exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites 206
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer 200
Characterization of the p53 mutants ability to inhibit p73b transactivation using a yeast-based functional assay 199
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential 197
Nucleotide excision repair defect influences lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent in the absence of base excision repair 196
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors 192
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements 190
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases 189
Caratterizzazione strutturale e funzionale di rnase6pl, un putativo gene oncosoppressore localizzato sul cromosoma 6 umano 186
STUDIO FUNZIONALE DI RNASE6PL, PUTATIVO GENE ONCOSOPRESSORE LOCALIZZATO IN 6Q27 186
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines. 186
Tumour p53 mutations exhibit promoter selective dominance over wild type p53 182
Lack of mutations in K-ras codons 12 and 13 in human atherosclerotic lesions. 182
Protective effect of inulin on LPS-induced intestinal smooth muscle impairment: a proteomic approach. 181
Gadd45 mutations are uncommon in human tumour cell lines 179
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 178
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements 178
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 177
Amifostine (WR2721) restores transcriptional activity of speci®c p53mutant proteins in a yeast functional assay 174
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. 173
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-Adenine methylating agent 170
Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. 168
Molecular characterization of RNASE6PL, a putative human tumor suppressor gene on chromosome 6q27. 166
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent. 162
N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic. 161
p53 mutations and DNA ploidy in colorectal adenocarcinomas. 158
PROLINE DEHYDROGENASE EXPRESSION, REGULATION AND FUNCTION IN NON-SMALL CELL LUNG CARCINOMA 158
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent 157
Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis. 157
Mutation spectrum of 4-nitroquinoline 1-oxide-damaged single-stranded shuttle vector DNA transfected into monkey cells. 155
RNASET2 is a non-cell autonomous human tumor suppressor 152
The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions. 152
TRPV4 and TRPM8 as putative targets for chronic low back pain alleviation 152
Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements. 151
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 150
p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients. 147
Human Primary Dermal Fibroblasts Interacting with 3-Dimensional Matrices for Surgical Application Show Specific Growth and Gene Expression Programs 145
p53 is frequently mutated in Barrett's metaplasia of the intestinal type. 144
Tumor and metastasis suppression by the human RNASET2 gene. 142
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence 141
The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts. 136
Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells. 132
Partial characterization of SUVi, a new mammalian gene induced by UV-C and expressed during the S phase of the cell cycle 131
Study on aneuploidy and p53 mutations in astrocytomas. 131
Stable formation of mutated p53 multimers in a Chinese hamster cell line causes defective p53 nuclear localization and abrogates its residual function. 130
Beyond conventional: The new horizon of anti-angiogenic micrornas in non-small cell lung cancer therapy 130
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 124
Study of 4-NQO induced mutations at the HPRT locus in CHO cell lines. Possible influences of preferential DNA-repair on the mutational spectrum. 123
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma 122
Serum miRNAs as biomarkers for early diagnosis of non small cell lung cancer 121
RNASET2, a putative oncosuppressor gene: cellular and biochemical characterization 119
Multi-system approach to study mutagenesis induced by chemical carcinogens. 119
FUNCTIONAL CHARACTERIZATION OF P53 MUTANT PROTEINS: A WAY FOR UNDERSTANDING THEIR ROLE IN CARCINOGENESIS 118
Mutation of p53 in the progression of Barrett's epithelium to invasive esophageal cancer: A prospective study 115
Genetic alterations in astrocytic tumors: hints to a molecular epidemiological interpretation. 109
Single stranded DNA-vectors for analyzing processing of DNA damage induced by 4-nitroquinoline-1-oxide in prokaryotes and eukaryotes. 109
The role of the medicinal leech HvRNASET2 enzyme during tissue remodeling 103
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression. 98
The medicinal leech HvRNASET2 enzyme as a promising molecule during tissue regeneration 86
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 76
The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy 73
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces 73
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 59
Editorial: The role of circular RNAs and MicroRNAs in non-small cell lung cancer: from mechanisms to therapeutic potential 18
Totale 16.093
Categoria #
all - tutte 59.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022616 0 0 0 39 38 37 62 70 65 124 68 113
2022/20231.244 104 75 88 147 83 268 69 155 131 41 45 38
2023/20241.763 283 268 265 299 329 145 20 26 58 8 15 47
2024/20251.910 10 17 223 71 203 135 130 176 240 156 160 389
2025/20264.254 347 235 352 639 476 282 694 320 354 277 153 125
2026/20271.313 110 219 573 411 0 0 0 0 0 0 0 0
Totale 16.093